SCHEMBL7201844

SCHEMBL7201844

O=S(=O)(O)CCC(O)CN1CCNCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.45
RAD52 P43351 1/20 0.40
BAX Q07812 2/20 0.38
MAPT P10636 2/20 0.37
CYP3A4 P08684 2/20 0.37
TP53 P04637 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
POLB P06746 1/20 0.37
LMNA P02545 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
IDO1 P14902 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.33
USP2 O75604 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM3 P20309 1/20 0.33
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12227827 0.87 KMT2A (0.41) SMN1; SMN2MAPTKDM4EALDH1A1MEN1
SCHEMBL6931945 0.82 SMN1; SMN2 (0.47) SMN1; SMN2RAD52BAXMAPTCYP3A4
SCHEMBL11438133 0.77 SMN1; SMN2 (0.60) SMN1; SMN2RAD52BAXMAPTCYP3A4
Sulfuric Acid SCHEMBL28700688 0.76 SMN1; SMN2 (0.43) SMN1; SMN2RAD52BAXMAPTCYP3A4
SCHEMBL1408785 0.76 SMN1; SMN2 (0.51) SMN1; SMN2RAD52BAXMAPTCYP3A4
SCHEMBL25262548 0.75 SMN1; SMN2 (0.44) SMN1; SMN2RAD52BAXMAPTCYP3A4
SCHEMBL151400 0.75 SMN1; SMN2 (0.58) SMN1; SMN2RAD52BAXMAPTCYP3A4
SCHEMBL2801591 0.74 SMN1; SMN2 (0.54) SMN1; SMN2RAD52BAXMAPTCYP3A4
SCHEMBL25948687 0.74 SMN1; SMN2 (0.50) SMN1; SMN2RAD52BAXMAPTCYP3A4
SCHEMBL7286319 0.74 SMN1; SMN2 (0.46) SMN1; SMN2RAD52BAXMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030110840-A1 Systems and methods for detecting a particle REGENTS OF THE UNIVERSITY OF MINNESOTA 2003-06-19 US disclosed
US-6482799-B1 Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-11-19 US disclosed
WO-2000071175-A1 OPHTHALMIC SOLUTIONS INCORPORATING AN ANTIMICROBIAL POLYPEPTIDE LARGE SCALE BIOLOGY CORPORATION (US) 2000-11-30 WO disclosed
EP-0524604-B1 Process for the preparations of S-(+)-2,2-dimethyl-cyclopropane carboxamid by genetically engineered microorganismes LONZA AG (CH) 1998-10-14 EP disclosed
EP-0502525-B1 Biotechnological process for the production of S-(+)-2,2-dimethylcyclopropanecarboxamide and R-(-)-2,2-dimethylcyclopropanecarboxylic acid LONZA AG (CH) 1996-06-26 EP disclosed
US-5427934-A A new DNA isolation from microorganism that codes for a stereospecific hydrolase, ligation of DNA in expression vector results hybrid plasmid, which is transformed in microorganism, which biotransform amide to acid and isomer of amide LONZA LTD. (CH) 1995-06-27 US disclosed
US-5360731-A Bacteria capable of stereospecifically hydrolyzing R-(-)-2,2-dimethylcyclopropanecarboxamide LONZA LTD. (CH) 1994-11-01 US disclosed
US-5273903-A Biotransforming the R(-) isomer in a racemic mixture with Comamonas or an enzyme from this microorganism LONZA LTD. (CH) 1993-12-28 US disclosed
EP-0524604-A2 Process for the preparations of S-(+)-2,2-dimethyl-cyclopropane carboxamid by genetically engineered microorganismes LONZA A.G. (CH) 1993-01-27 EP disclosed
EP-0502525-A1 Biotechnological process for the production of S-(+)-2,2-dimethylcyclopropanecarboxamide and R-(-)-2,2-dimethylcyclopropanecarboxylic acid LONZA AG (CH) 1992-09-09 EP disclosed